Sort
261,768 grants matching “gene therapy”
DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM
$1,421,967University Of Texas Sw Med Ctr/Dallas · P01 · FY2001 · DK
Human Melanoma: Etiology, Progression and Therapy
$1,421,890Meenhard Herlyn · Wistar Institute · P01 · FY2012 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$1,421,723Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES
$1,421,694City Of Hope/Beckman Research Institute · P01 · FY2002 · HL
Identification of genetic interactors of Brca2
$1,421,526Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,421,482David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2015 · AI
DCTD Computer Support
$1,421,384David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Whole blood filter paper assay for Alzheimers Disease
$1,421,226Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2023 · AG
Impact of Stretching on Tumor growth and Metastasis
$1,421,200Lisbeth Berrueta · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
$1,420,853Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R44 · FY2025 · CA
Accelerate Clinical Trials in CMT (ACTCMT) Study
$1,420,775David N Herrmann · University Of Rochester · U01 · FY2019 · NS
Mechanisms of transcriptional and replicative mutagenesis
$1,420,696Paul Doetsch · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Improving Retroviral Vectors for Gene Delivery
$1,420,568University Of Southern California · P01 · FY2002 · CA
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,420,487Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2015 · CA
COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS
$1,420,487Scott Powers · Cold Spring Harbor Laboratory · U01 · FY2016 · CA
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,420,391Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,420,345Chi-Chao Chan · National Eye Institute · ZIA · FY2010 · EY
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,420,204Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
The neurobehavioral, environmental and genetic factors impacting ADHD.
$1,420,020Wallace Philip Shaw · National Human Genome Research Institute · ZIA · FY2014 · HG
H. pylori-induced Inflammation and Gastric Cancer
$1,419,975Richard M Peek · Vanderbilt University Medical Center · P01 · FY2019 · CA
LEAD PROJECT 1: PHENYLKETONURIA (PKU)
$1,419,953Kiran Musunuru · Children'S Hosp Of Philadelphia · U19 · FY2024 · NS
Muscular Dystrophy Cooperative Research Center
$1,419,867Richard T Moxley · University Of Rochester · U54 · FY2007 · NS
Susceptibility Patterns for Grade C Periodontitis in Young Individuals
$1,419,503Luciana Macchion Shaddox · University Of Kentucky · U01 · FY2025 · DE
Mechanisms Responsible for Impairment of Neocortical Development by Cocaine
$1,419,491William Freed · National Institute On Drug Abuse · ZIA · FY2009 · DA
Molecular Mechanisms of Fate Choice in Neural Stem Cells
$1,419,279Dana-Farber Cancer Institute · P01 · FY2004 · NS